文献速递MDS 与骨髓增殖性肿瘤造血干细胞移植与细胞治疗

利用机器学习技术预测骨髓纤维化患者造血细胞移植后不良生存

Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis.
PubMed 文献 · Blood · 2025-01-01

研究基于欧洲血液与骨髓移植学会中心2005至2020年间5183例首次接受异基因造血细胞移植的骨髓纤维化患者数据,比较多种机器学习模型预测移植后总生存。随机生存森林模型基于10个变量开发,在训练集(75%)和测试集(25%)中优于4级Cox回归评分、其他机器学习模型及国际血液与骨髓移植研究中心评分,能有效识别占25%的高风险组。

要点

  • 随机生存森林模型基于年龄、合并症指数、体能状态、血原始细胞、血红蛋白、白细胞、血小板、供者类型、预处理强度和移植物抗宿主病预防10个变量构建。
  • 随机生存森林模型在主要及原发性血小板增多症/真性红细胞增多症后骨髓纤维化亚组中一致性指数均优于所有对照模型。
  • 随机生存森林模型曲线分离更优,可识别占25%的高风险患者组。

核心结论

  • 机器学习可增强接受异基因造血细胞移植的骨髓纤维化患者的风险分层,为个性化医疗铺路。
  • 基于随机生存森林模型的网络应用可识别移植结局不良的高风险患者,支持知情治疗决策并推进个体化照护。

研究设计与样本

  • 使用欧洲血液与骨髓移植学会中心2005至2020年间5183例首次接受异基因造血细胞移植的骨髓纤维化患者数据。
  • 队列分为训练集(75%)和测试集(25%)用于模型验证。
  • 开发基于10个变量的随机生存森林模型,并与4级Cox回归评分、同一数据集衍生的其他机器学习模型及国际血液与骨髓移植研究中心评分比较。

主要发现

  • 随机生存森林模型优于所有对照模型,在主要及原发性血小板增多症/真性红细胞增多症后骨髓纤维化亚组中一致性指数均更优。
  • 赤池信息准则和时间依赖受试者工作特征曲线下面积指标在训练集和测试集中均证实随机生存森林模型的稳健性和泛化性。
  • 所有模型对非复发死亡均有预后价值,但随机生存森林模型曲线分离更优,有效识别占25%患者的高风险组。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

With the incorporation of effective therapies for myelofibrosis (MF), accurately predicting outcomes after allogeneic hematopoietic cell transplantation (allo-HCT) is crucial for determining the optimal timing for this procedure. Using data from 5183 patients with MF who underwent first allo-HCT between 2005 and 2020 at European Society for Blood and Marrow Transplantation centers, we examined different machine learning (ML) models to predict overall survival after transplant. The cohort was divided into a training set (75%) and a test set (25%) for model validation. A random survival forests (RSF) model was developed based on 10 variables: patient age, comorbidity index, performance status, blood blasts, hemoglobin, leukocytes, platelets, donor type, conditioning intensity, and graft-versus-host disease prophylaxis. Its performance was compared with a 4-level Cox regression-based score and other ML-based models derived from the same data set, and with the Center for International Blood and Marrow Transplant Research score. The RSF outperformed all comparators, achieving better concordance indices across both primary and postessential thrombocythemia/polycythemia vera MF subgroups. The robustness and generalizability of the RSF model was confirmed by Akaike information criterion and time-dependent receiver operating characteristic area under the curve metrics in both sets. Although all models were prognostic for nonrelapse mortality, the RSF provided better curve separation, effectively identifying a high-risk group comprising 25% of patients. In conclusion, ML enhances risk stratification in patients with MF undergoing allo-HCT, paving the way for personalized medicine. A web application (https://gemfin.click/ebmt) based on the RSF model offers a practical tool to identify patients at high risk for poor transplantation outcomes, supporting informed treatment decisions and advancing individualized care.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Hernández-Boluda JC, Mosquera-Orgueira A, Gras L, et al. Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosis. Blood. 2025. PMID: 40145857. doi:10.1182/blood.2024027287

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。